BioPassport Token
BIOT - # 648 ActiveKorean Asset
-
Rating Score 38.56Rating Grade D
- Rating Version APYWA-v1.1 / Rating Date 2025-12-22
Overview
BioPassport Token (BIOT) is a blockchain-based platform for digital biometrics and identity verification, providing an environment where users can securely protect and manage personal information and biometric data. BioPassport supports digital identity management and secure authentication through smart contracts, and the BIOT token is used for accessing services, participating in governance, and paying transaction fees. The platform aims to enhance privacy protection and build digital trust.
Metric Radar Chart
Metric Bar Chart
Metric Trends
| Total Rating Score | TNNeutral |
|---|---|
| Market Accessibility | TNNeutral |
| Development Activity | TNNeutral |
| Market Liquidity | TNNeutral |
| Community Engagement | TNNeutral |
| Risk & Security | TNNeutral |
Total Rating Score Trend
Market Data
- Token Price $0.000342 (↗7.55%)
- Volume (24h) $1.07M (↗1,230.17%)
- Market Cap $2.96M (↗11.90%)
-
Circulating Supply
8,659,948,356 BIOT
0 BIOT
(Source : Coinmarketcap , Coingecko )
Listed Exchanges
- Korean
-
- Global
×
View All Exchanges
- Korean
-
- Global
Community Info
X (Twitter) Tweets (Last 30 Days)
- (-)
Development Info
-
GitHub Account
biopassport
-
Stars
0 (-)
- Commits (Last 3 Months) 0 (-)
Security Audit Info
- Security Audit Status None
- CertiK Code Security Score 55 pts
(Source : Coinmarketcap , CertiK Skynet )
Issue Info
- Trading History
- No records found
- Risk History
- No records found
View Full History
| Category | Date | Exchange | Link | Grade | Details |
|---|---|---|---|---|---|
| Regular Evaluation | 2025-10-13 | - | - | D(37.16) | [AW-0099-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-10-09 | - | - | D(37.16) | [AW-0098-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-10-06 | - | - | D(36.71) | [AW-0097-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-10-02 | - | - | D(36.71) | [AW-0096-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-09-29 | - | - | D(36.71) | [AW-0095-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-09-25 | - | - | D(36.61) | [AW-0094-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-09-22 | - | - | D(37.21) | [AW-0093-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-09-18 | - | - | D(36.61) | [AW-0092-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-09-15 | - | - | D(38.85) | [AW-0091-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-09-11 | - | - | D(36.96) | [AW-0090-정기] 평가가 완료되었습니다. |
- Disclaimer
-
The ratings provided by APYWA (hereinafter 'the Company') are conducted via an automated system based on public data and are pure data-driven analysis results with no subjective elements. This rating material includes evaluations on five key metrics: Market Accessibility, Development Activity, Market Liquidity, Community Engagement, and Security. All information provided is for reference purposes only.
Our ratings are not intended as investment advice or recommendations, and we do not guarantee the accuracy, completeness, or timeliness of the information. Users must make their own investment decisions based on the provided data, and the Company bears no legal liability for any resulting losses or damages.
While the rating material is processed automatically based on reliable data, discrepancies with actual market conditions may occur due to data limitations. Therefore, the Company is not liable for any damages arising from the use of the provided information. All information contained herein is the property of the Company and may not be reproduced, distributed, or modified without prior approval.